Home > Insider Trading > Filing (0001209191-17-002446)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1415336	Zeltiq Aesthetics Inc	ZLTQ	Electromedical & Electrotherapeutic Apparatus (3845)	270119051

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1417973	J Keith Sullivan	C/O Zeltiq Aesthetics, Inc. 4410 Rosewood Drive Pleasanton CA 94588	Cco, President, North America	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-01-04	8,000	$6.21	87,198	No	4	M	Direct
Common Stock	Disposition	2017-01-04	7,700	$44.34	79,498	No	4	S	Direct
Common Stock	Disposition	2017-01-04	100	$44.89	79,398	No	4	S	Direct
Common Stock	Disposition	2017-01-04	100	$44.90	79,298	No	4	S	Direct
Common Stock	Disposition	2017-01-04	100	$44.91	79,198	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-01-04	8,000	$0.00	8,000	$6.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
74,000		2022-10-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,000	Indirect	By Keith J Sullivan (IRA) FCC as custodian

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.